Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 5-methoxy-N,N-diethyltryptamine (5-MeO-DET), and N,N-diisopropyltryptamine (DiPT) in Schedule I; Announcement of Hearing
scheduling · Proposed Rule · Notice of hearing on proposed rulemaking. · Published 2022-07-06 · 87 FR 40167
Document
Document number
2022-14372
Federal Register citation
87 FR 40167
Type
Proposed Rule
Action
Notice of hearing on proposed rulemaking.
Category
scheduling
Publication date
2022-07-06
Abstract
This is notice that the Drug Enforcement Administration will hold a hearing with respect to the proposed placement of five tryptamine hallucinogens, as identified in the proposed rule, in schedule I of the Controlled Substances Act. The control of the five tryptamines was initially proposed in a Notice of Proposed Rulemaking published in the Federal Register on January 14, 2022.